Supplementary protection
LT - Arilo, heteroarilo ir heterocikliniai junginiai, skirti komplemento nulemtiems sutrikimams gydyti
EN - ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
4129407
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2025 514 |
| (22) |
Date of filing the application |
2025-04-08 |
| (41) |
Date of publication of the application |
2025-04-25 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Achillion Pharmaceuticals, Inc. ,
121 Seaport Blvd., Boston, MA 02210,
US
|
Grantee
| (73) |
Achillion Pharmaceuticals, Inc. ,
121 Seaport Blvd., Boston, MA 02210,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/24/1792, 2024-04-19
|
Name of the product protected by the basic patent
| (95) |
Danikopanas arba jo farmaciniu požiūriu priimtina druska |
Legal status
|
SPC application published
|
|
